This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Johnson & Johnson is recalling sunscreens from two of its popular brands over concerns of carcinogenic benzene contamination. The company said that while benzene is not an ingredient in any of its sunscreen products, it was detected during routine internal testing in some samples of its aerosol sunscreen finished products.
SUMMARY: Pharmacompanies, like J&J, have received criticism for engaging in illegal activities, such as providing kickbacks and bribes, knowingly shipping adulterated or contaminated drugs to pharmacies, and marketing drugs for unapproved uses. Johnson & Johnson has paid $2.7 billion in penalties.
The top ten pharmacompanies in 2023 by revenue accounted for about 35 percent of the market value, with total earnings of $559.5 The top big pharma players have remained relatively consistent in their market positions over the past several years. Here is a look at the top ten pharmacompanies in 2024 based on 2023 revenue.
In this ongoing series , we put a spotlight on contracts between pharmacompanies and contract manufacturing organizations (CMOs). In 2021, the US FDA had decreed that about 60 million doses of the vaccine made at Emergent’s factory be discarded after a batch was contaminated. .
Water-borne illnesses are also likely to become more common, as increased rain and storm surges contribute to flooding and contaminated run off. Just as in the wake of COVID-19, the world will look to pharma to fulfil its public health needs. Vulnerability . Making plans is not enough.
Pharmacompanies involved in the sale of heartburn therapy Zantac have won a key battle in litigation brought by patients who claim the drug caused them to develop cancer.
Vials can hold more doses of the vaccine, allowing for more vaccinations and a lower cost, but prefilled syringes allow for easier administration, reduced risk of contamination, minimised risk of injuries during use and improved accuracy. Cost is an important final factor, especially for small and mid-sized pharmacompanies.
Brian Duncan, chief operating officer of QxP, which provides the Virtuousi VR tool enabling pharmacompanies to train staff on manufacturing treatments, told pharmaphorum that VR is part of a longer chain that ensures that innovative and more complex therapies can be produced effectively.
At Creogenic Pharma, we have a dedicated workforce of professionals and a cGMP compliant manufacturing facility. We also have contamination-free spacious warehouses and link-ups with certified vendors in the industry. SEND ENQUIRY [contact-form-7] The post Best Cough Syrups in India appeared first on Creogenic Pharma.
The first lawsuit claiming that gastrointestinal drug Zantac causes cancer has been voluntarily dismissed a week before it was due to come to trial, in an early victory for the pharmacompanies that will defend themselves from the allegations. “GSK will continue to vigorously defend itself against all claims alleging otherwise.”
Another task for Pharma Consultants is Pharmacovigilance that is relatable to the collection, detection, assessment, monitoring, and prevention of adverse effects with biologicals, they also work in the area of resolving contamination issues. Pharma Consultancy Modus Operandi. Market Assessment & Operational Sales.
Yet while demand for injectables soars, regulators are cracking down on quality requirements, forcing many pharmacompanies to examine the role – and risks – of their primary packaging. In addition, packaging components are not entirely manufactured in a clean room environment, making them a potential source of exogenous contamination.
When freeze drying sterile pharmaceuticals, mass spectrometry helps manufacturers protect valuable batches from silicone oil contamination – a possible risk of the lyophilisation process. Preventing silicone oil contamination Silicone oil is a common component of lyophilisation systems.
This, coupled with small pharmacompanies being unable to acquire or access containment capabilities in-house, means that the demand for innovative specialized small molecule capabilities remains high. Furthermore, the number of marketed high potency APIs (HPAPIs) tends to increase over time as more HPAPIs in development gain approval.
per share in cash, following a 2020 deal that left the larger pharmacompany with 60% of the latter company’s outstanding shares. The bacterial species is commonly spread in healthcare facilities through direct contact between hands and contaminated surfaces, causing further risk to patients.
Cross-contamination of standard products with highly potent ones is another key concern. Most importantly, the machines themselves are highly user friendly – something which has been appreciated by pharmacompanies and university laboratories around the world. Containment is paired with a loss of ergonomics in most cases.
This reduces human error and contamination risks, ensuring higher-quality production outcomes. For example, NGS-based whole-genome shotgun sequencing and transcriptomics provide valuable data for researchers and pharmacompanies, facilitating drug discovery and development, particularly in microbiome-related studies.
While RT-PCR methods can handle some level of multiplexing, they do require specialized, contamination-free environments. Rapid assays that can deliver same-day results are highly attractive to pharmacompanies, as they eliminate lengthy sample queues often seen with centralized or outsourced testing.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content